SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-19-004731
Filing Date
2019-08-13
Accepted
2019-08-13 16:10:15
Documents
1
Period of Report
2019-09-19
Effectiveness Date
2019-08-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ipix_def14a.htm DEF 14A 114255
  Complete submission text file 0001477932-19-004731.txt   115505
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-37357 | Film No.: 191020722
SIC: 2834 Pharmaceutical Preparations